+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

What Evidence Do We Have for Pharmaceutical Galactagogues in the Treatment of Lactation Insufficiency?-A Narrative Review

What Evidence Do We Have for Pharmaceutical Galactagogues in the Treatment of Lactation Insufficiency?-A Narrative Review

Nutrients 11(5):

Inadequate breast milk supply is a frequently reported reason for early discontinuation of breastfeeding and represents a critical opportunity for intervening to improve breastfeeding outcomes. For women who continue to experience insufficient milk supply despite the utilisation of non-pharmacological lactation support strategies, pharmacological intervention with medications used to augment lactation, commonly referred to as galactagogues, is common. Galactagogues exert their pharmacological effects through altering the complex hormonal milieu regulating lactation, particularly prolactin and oxytocin. This narrative review provides an appraisal of the existing evidence regarding the efficacy and safety of pharmaceutical treatments for lactation insufficiency to guide their use in clinical practice. The greatest body of evidence surrounds the use of domperidone, with studies demonstrating moderate short-term improvements in breast milk supply. Evidence regarding the efficacy and safety of metoclopramide is less robust, but given that it shares the same mechanism of action as domperidone it may represent a potential treatment alternative where domperidone is unsuitable. Data on remaining interventions such as oxytocin, prolactin and metformin is too limited to support their use in clinical practice. The review provides an overview of key evidence gaps and areas of future research, including the impacts of pharmaceutical galactagogues on breast milk composition and understanding factors contributing to individual treatment response to pharmaceutical galactagogues.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 066736295

Download citation: RISBibTeXText

PMID: 31035376

DOI: 10.3390/nu11050974

Related references

A critical review of pharmaceutical galactagogues. Breastfeeding Medicine 2(4): 229-242, 2007

A Review of Herbal and Pharmaceutical Galactagogues for Breast-Feeding. Ochsner Journal 16(4): 511-524, 2016

Phone calls to an Australian pregnancy and lactation counselling service regarding use of galactagogues during lactation - the MotherSafe experience. Australian and new Zealand Journal of Obstetrics and Gynaecology 58(2): 251-254, 2018

Pharmaceutical treatment of lactation deficiency lacks evidence. Ugeskrift for Laeger 176(9a): V06130415, 2014

Use and value of common European lactation-promoting medicinal plants (galactagogues). Padiatrie und Grenzgebiete 28(6): 403-410, 1989

Vitamin D testing and treatment: a narrative review of current evidence. Endocrine Connections 8(2): R27-R43, 2019

Maternal experiences with and sources of information on galactagogues to support lactation: a cross-sectional study. International Journal of Women's Health 9: 105-113, 2017

Where is the Evidence? A Narrative Literature Review of the Treatment Modalities for Autism Spectrum Disorders. Cureus 11(1): E3901, 2019

Pregnancy- and lactation-associated osteoporosis: a narrative mini-review. Endocrine Regulations 45(1): 43-47, 2011

Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem. Annals of Internal Medicine 145(7): 520-530, 2006

Towards a cognitive-learning formulation of youth anxiety: A narrative review of theory and evidence and implications for treatment. Clinical Psychology Review 50: 50-66, 2016

Can antiviral treatment for hepatitis C be safely and effectively delivered in primary care?: a narrative systematic review of the evidence base. British Journal of General Practice 63(617): E842-E851, 2013

A Narrative Review of Psychological Cannabis Use Treatments with And Without Pharmaceutical Adjunct. Current Pharmaceutical Design 22(42): 6397-6408, 2016

Variation in the Protein Composition of Human Milk during Extended Lactation: A Narrative Review. Nutrients 10(8):, 2018

Pharmaceutical Pricing Policies and Procedures in Saudi Arabia: A Narrative Review. Therapeutic Innovation and Regulatory Science 50(2): 236-240, 2016